Unknown

Dataset Information

0

Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.


ABSTRACT:

Background

Lymphatic filariasis (LF) is targeted for elimination in Sierra Leone. Epidemiological coverage of mass drug administration (MDA) with ivermectin and albendazole had been reported >65% in all 12 districts annually. Eight districts qualified to implement transmission assessment survey (TAS) in 2013 but were deferred until 2017 due to the Ebola outbreak (2014-2016). In 2017, four districts qualified for conducting a repeat pre-TAS after completing three more rounds of MDA and the final two districts were also eligible to implement a pre-TAS.

Methodology/principal findings

For TAS, eight districts were surveyed as four evaluation units (EU). A school-based survey was conducted in children aged 6-7 years from 30 clusters per EU. For pre-TAS, one sentinel and one spot check site per district (with 2 spot check sites in Bombali) were selected and 300-350 persons aged 5 years and above were selected. For both surveys, finger prick blood samples were tested using the Filariasis Test Strips (FTS). For TAS, 7,143 children aged 6-7 years were surveyed across four EUs, and positives were found in three EUs, all below the critical cut-off value for each EU. For the repeat pre-TAS/pre-TAS, 3,994 persons over five years of age were surveyed. The Western Area Urban had FTS prevalence of 0.7% in two sites and qualified for TAS, while other five districts had sites with antigenemia prevalence >2%: 9.1-25.9% in Bombali, 7.5-19.4% in Koinadugu, 6.1-2.9% in Kailahun, 1.3-2.3% in Kenema and 1.7% - 3.7% in Western Area Rural.

Conclusions/significance

Eight districts in Sierra Leone have successfully passed TAS1 and stopped MDA, with one more district qualified for conducting TAS1, a significant progress towards LF elimination. However, great challenges exist in eliminating LF from the whole country with repeated failure of pre-TAS in border districts. Effort needs to be intensified to achieve LF elimination.

SUBMITTER: Bah YM 

PROVIDER: S-EPMC7793261 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Achievements and challenges of lymphatic filariasis elimination in Sierra Leone.

Bah Yakuba M YM   Paye Jusufu J   Bah Mohamed S MS   Conteh Abdulai A   Redwood-Sawyerr Victoria V   Sonnie Mustapha M   Veinoglou Amy A   Koroma Joseph B JB   Hodges Mary H MH   Zhang Yaobi Y  

PLoS neglected tropical diseases 20201228 12


<h4>Background</h4>Lymphatic filariasis (LF) is targeted for elimination in Sierra Leone. Epidemiological coverage of mass drug administration (MDA) with ivermectin and albendazole had been reported >65% in all 12 districts annually. Eight districts qualified to implement transmission assessment survey (TAS) in 2013 but were deferred until 2017 due to the Ebola outbreak (2014-2016). In 2017, four districts qualified for conducting a repeat pre-TAS after completing three more rounds of MDA and th  ...[more]

Similar Datasets

| S-EPMC6685173 | biostudies-literature
| S-EPMC6160210 | biostudies-literature
| S-EPMC6922463 | biostudies-literature
| S-EPMC3681681 | biostudies-literature
| S-EPMC4364952 | biostudies-literature
| S-EPMC7413036 | biostudies-literature
| S-EPMC3916318 | biostudies-other
| S-EPMC7252669 | biostudies-literature
| S-EPMC7592542 | biostudies-literature
| S-EPMC4177192 | biostudies-literature